<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02922036</url>
  </required_header>
  <id_info>
    <org_study_id>CSP-03035</org_study_id>
    <nct_id>NCT02922036</nct_id>
  </id_info>
  <brief_title>Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients</brief_title>
  <acronym>SOLVE-CRT</acronym>
  <official_title>Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EBR Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EBR Systems, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of&#xD;
      the WiSE-CRT System for Cardiac Re-synchronization Therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The WiSE-CRT System is an implantable cardiac pacing system capable of delivering pacing&#xD;
      energy to the left ventricle of the heart without using a pacing lead.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety</measure>
    <time_frame>6 Months</time_frame>
    <description>Freedom from Procedure and Device System related Type 1 Complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Efficacy 1</measure>
    <time_frame>6 Months</time_frame>
    <description>Mean relative % change in Left Ventricular End Systolic Volume (LVESV) baseline to 6 Months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy 1</measure>
    <time_frame>6 Months</time_frame>
    <description>Electrode Acoustic Pacing Capture Threshold (APCT) measured at the 6-month follow-up post-implant visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy 2</measure>
    <time_frame>6 Months</time_frame>
    <description>Electrode Acoustic Pacing Capture Threshold Stability (APCT Stability) measured from pre-discharge through the 6-month follow-up post-implant visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy 3</measure>
    <time_frame>6 months</time_frame>
    <description>% Bi-ventricular pacing (total number of WiSE paced beats / total number of co-implant RV-paced beats) at 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy 4</measure>
    <time_frame>6 months</time_frame>
    <description>EF responder analysis for ≥ 5% absolute increase from baseline to 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy 5</measure>
    <time_frame>6 months</time_frame>
    <description>KCCQ responder analysis for ≥ 5 points absolute increase from baseline to 6 months</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>WiSE System therapy ON with Guideline Directed Medical Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WiSE System</intervention_name>
    <description>The WiSE System is an implantable cardiac system to provide LV pacing stimulation in conjunction with a co-implanted system that provides right ventricular stimulation.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion/Exclusion:&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          1. Patient with a class I or IIa (1) or (2) indication for implantation of a CRT-D device&#xD;
             according to current available guidelines (with additional QRS criteria on Class IIa&#xD;
             (1)):&#xD;
&#xD;
               1. Class I: NYHA II, III, IV, EF ≤ 35%, LBBB, QRS ≥ 150ms&#xD;
&#xD;
               2. Class IIa (1): NYHA II, III, IV, EF≤ 35%, LBBB, QRS ≥ 130 to &lt; 150ms&#xD;
&#xD;
               3. Class IIa (2): NYHA II, III, IV, EF≤ 35%, non-LBBB, QRS ≥ 150ms&#xD;
&#xD;
          2. Patient is a:&#xD;
&#xD;
               1. 'Non-responder' [Not Enrolling]: Patients who have a CRT system that is&#xD;
                  functional and despite an adequate trial of Guideline Directed Medical Therapy&#xD;
                  (GDMT) and attempts at optimal device programming the patient has not responded&#xD;
                  to therapy for a minimum of 6 months. Non-response is defined as:&#xD;
&#xD;
                    -  EF has remained unchanged or worsened (defined as &lt; 5% increase since&#xD;
                       implant), and&#xD;
&#xD;
                    -  The patient's clinical status based in the totality of available clinical&#xD;
                       evidence (such as NYHA Class, exercise tolerance, QOL, or global assessment)&#xD;
                       has remained unchanged or worsened, as determined by the local Site&#xD;
                       Enrollment Committee&#xD;
&#xD;
                  OR&#xD;
&#xD;
               2. 'Previously Untreatable': Patients who have a full or partial CRT system, who&#xD;
                  meet general inclusion criteria and are deemed as 'previously untreatable' for&#xD;
                  one of the following reasons:&#xD;
&#xD;
             i. Patients in whom CS lead implantation for CRT has failed&#xD;
&#xD;
               -  CS lead implant was attempted but abandoned due any of the following: difficult&#xD;
                  CS access or anatomy, inadequate lead location, inadequate pacing thresholds,&#xD;
                  persistent phrenic nerve pacing, or other procedural challenges&#xD;
&#xD;
             ii. CS lead implanted but has been programmed OFF&#xD;
&#xD;
               -  LV lead that was implanted but not operational includes patients in whom the LV&#xD;
                  lead is inoperative or programmed off due to improper function such as high&#xD;
                  threshold, non-capture, phrenic nerve pacing, lead failure, lead dislodgement, or&#xD;
                  sub-optimal LV lead location&#xD;
&#xD;
             OR&#xD;
&#xD;
             c. 'High Risk Upgrade:&#xD;
&#xD;
             Patients who have a relative contraindication to CS lead implant, due to:&#xD;
&#xD;
               -  venous occlusion or lesion precluding implant&#xD;
&#xD;
               -  pocket infection risk (at co-implanted device site)&#xD;
&#xD;
               -  considered high risk for CS implant due to co-morbidities&#xD;
&#xD;
          3. Patients on a stable Guideline Directed Medical Therapy (GDMT)&#xD;
&#xD;
          4. Patient must be 18 years old or over&#xD;
&#xD;
          5. Patient has signed and dated informed consent&#xD;
&#xD;
          6. Patient has suitable anatomy for implant of the WiSE CRT System (e.g. adequate&#xD;
             acoustic window, LV wall thickness in target implant area ≥ 5 mm, absence of LV wall&#xD;
             structural abnormalities which may preclude implant)&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Patients who meet any one of these criteria will be excluded from the investigation:&#xD;
&#xD;
          1. Pure RBBB&#xD;
&#xD;
          2. LVEDD ≥ 8cm&#xD;
&#xD;
          3. Non-ambulatory or unstable NYHA class IV&#xD;
&#xD;
          4. Contraindication to heparin, chronic anticoagulants or antiplatelet agents&#xD;
&#xD;
          5. Triple anticoagulant patients who cannot tolerate peri-procedural stopping of&#xD;
             anticoagulation therapy&#xD;
&#xD;
          6. Attempted device implant (pacemaker, ICD, CRT, LV lead) or successful co-implant&#xD;
             within prior 30 days.&#xD;
&#xD;
          7. Patients with planned or expected lithotripsy treatment post implant&#xD;
&#xD;
          8. Life expectancy of &lt; 12 months&#xD;
&#xD;
          9. Chronic hemodialysis&#xD;
&#xD;
         10. Stage 4 or 5 renal dysfunction defined as eGFR &lt; 30&#xD;
&#xD;
         11. Grade 4 mitral valve regurgitation&#xD;
&#xD;
         12. Noncardiac implanted electrical stimulation therapy devices&#xD;
&#xD;
         13. Patients with a prosthetic aortic valve in which the electrode cannot be implanted via&#xD;
             a transseptal approach&#xD;
&#xD;
         14. Patients with a prosthetic mitral valve in which the electrode cannot be implanted via&#xD;
             a retrograde aortic approach&#xD;
&#xD;
         15. Unstable angina, acute MI, CABG, or PTCA within the past 1 month&#xD;
&#xD;
         16. Correctable valvular disease that is the primary cause of heart failure&#xD;
&#xD;
         17. Recent CVA or TIA (within the previous 3 months)&#xD;
&#xD;
         18. Patients with a history of paroxysmal or persistent atrial fibrillation/flutter are&#xD;
             excluded if they have had a documented AF episode &gt; 30 min or a cardioversion in the&#xD;
             past 1 month.&#xD;
&#xD;
         19. Patients with permanent AF are excluded if they have intact AV node conduction (RV&#xD;
             pacing &lt;95%)&#xD;
&#xD;
         20. Already included in another clinical study that could confound the results of this&#xD;
             study&#xD;
&#xD;
         21. Pregnancy&#xD;
&#xD;
         22. Known drug or alcohol addiction or abuse&#xD;
&#xD;
         23. Moderate or severe aortic stenosis&#xD;
&#xD;
         24. Positive test for COVID-19 at screening&#xD;
&#xD;
         25. Subject unable to attend follow-up at the investigative center or unable, for physical&#xD;
             or mental reasons, or to comply with the trial's procedures&#xD;
&#xD;
         26. For Part II Randomized patients only, those who will not tolerate being randomized to&#xD;
             the Control Group for 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jagmeet Singh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary N Walsh, MD, MACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Vincent Heart Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paulette Niemyski</last_name>
    <phone>6307405721</phone>
    <email>paulette.niemyski@ebrsystemsinc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banner University Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Wilbur Su, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keck Medical Center of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melissa Ramos, RN, CCRP</last_name>
      <phone>323-442-7983</phone>
      <email>melissa.ramos@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Ivan Ho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sequoia Hospital</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zayna Shaheen</last_name>
      <email>zayna.shaheen@dignityhealth.org</email>
    </contact>
    <investigator>
      <last_name>Dr. Hardwin Mead, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joseph Akar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Broward Health Medical Center</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Ayer, MSN, CCRP</last_name>
      <email>dayer@browardhealth.org</email>
    </contact>
    <investigator>
      <last_name>Ahmed Osman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Healthcare</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Champagne</last_name>
      <email>Tracy.Champagne@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Dr. Saumil Oza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sandeep Goyal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory Healthcare</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Faisal Merchant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Heart</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62769</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. John Scherschel</last_name>
      <email>jschersc@prairieheart.com</email>
    </contact>
    <contact_backup>
      <last_name>Kathlena (Katie) Mottershaw</last_name>
      <email>KMottershaw@prairieresearch.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital and Healthcare Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Bogard</last_name>
      <phone>317-338-6450</phone>
      <email>laurie.bogard@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Eric Prystowsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Giudici, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gery Tomassoni, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kevin Heist, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Lahiri, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sparrow Hospital</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Ip, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Frost</last_name>
      <email>Frost.hannah@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Yong-Mei Cha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United Heart and Vascular Clinic</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Gernes</last_name>
      <phone>651-241-2216</phone>
      <email>Nicole.Gernes@allina.com</email>
    </contact>
    <investigator>
      <last_name>Alan Bank, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Physicians Heart Clinic Consultants</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matthew Latacha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc Miller, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Ip, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Niraj Varma, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toshimasa Okabe, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Heart and Vascular Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir Saba, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MUSC Gazes Research Institute</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debi Everidge, MD</last_name>
      <phone>843-876-4762</phone>
      <email>adamsde@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Lacy Studivant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular Center</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Frank McGrew, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Dragutsky</last_name>
    </contact>
    <investigator>
      <last_name>Frank McGrew, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nichole Piece</last_name>
    </contact>
    <investigator>
      <last_name>Nilesh Mathuira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mary Pierce</last_name>
      <email>Mary.H.Pierce@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Dr. Saumya Sharma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Kindsvater, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Destiny Barnett</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Houston Methodist</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Apoor Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kenneth Ellenbogen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Imran Niazi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Canberra Hospital</name>
      <address>
        <city>Garran</city>
        <state>Canberra</state>
        <zip>2605</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton Heights</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prash Sanders, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monash Heart</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble - Hopital Michallon Service de Cardiologie</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>APHM-Hopital de La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Cardiologique du Nord</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU-Hopital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur Cardiologie &amp; Rythmologie</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Immanuel Klinikum Bernau - Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau</city>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitäres Herzzentrum Hamburg (UKE Hamburg) GmbH (UHZ)</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Orsola - Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale San Gerardo</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Isala Hartcentrum</name>
      <address>
        <city>Zwolle</city>
        <zip>8025 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Liverpool Heart and Chest Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L14 3PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Barts Heart Centre</name>
      <address>
        <city>London</city>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aldo Rinaldi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Manchester Heart Centre</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 27, 2016</study_first_submitted>
  <study_first_submitted_qc>September 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2016</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

